The European Commission is still negotiating with the American pharmaceutical company Moderna about the supply of corona vaccines.
At the end of August, the biotechnology company itself announced that it was in talks with the executive board of the EU about the delivery of 80 million doses, with an option for an additional 80 million if the vaccine proved safe and effective.
According to Commissioner Stella Kyriakides (Health), negotiations are still ongoing, she said in the European Parliament.
Moderna announced on Monday that, according to preliminary research results, the vaccine is 94.5 percent effective in preventing infection with the coronavirus. Kyriakides tweeted that the news is “encouraging.”
She also announced that she would sign the contract with Pfizer-BioNTech “later this week”.
With this American / German combination, Brussels has an agreement in principle for the delivery of 200 million doses and an option for an additional 100 million doses. According to the company, that vaccine is 90 percent effective.